O.T. "STEM" - Substantial Upside Over Next 6 Months!!!
"STEM" is substantially undervalued. Company raised $12.5 million at the beginning of November and now has cash on hand for almost two years of operation. Company owns more than 55 patents in the area of stem cells for medical applications – see link below. Substantial intellectual and intrinsic value in these patents. Share price is currently at the low end of its 52 week range. NIH recently began approving applications for numerous research projects involving embryonic stem cell research. Substantial upside both short and long term. Potential takeover target. Due diligence but do check it out. Realistic One Year Target: $4.00